SEARCH RESULTS FOR: ablation(17623 results)
Only the first 10,000 results were returned. Filter these results or refine your query. Some pre-built queries with more than 10,000 results are available for download.
CART OCA01 OSTEOCOOL CART STAND
MEDTRONIC SOFAMOR DANEK, INC.
OCA01
In Commercial Distribution
- 00643169585669 ()
- Medical device integration rack
STAND OCA02 OSTEOCOOL DESK STAND
MEDTRONIC SOFAMOR DANEK, INC.
OCA02
In Commercial Distribution
- 00643169585652 ()
- Medical device integration rack
Intended for incision, excision, vaporization, ablation, hemostasis and coagulation of soft tissue.
CeramOptec GmbH
Leonardo® Mini Blue
In Commercial Distribution
- 04049059301146 ()
- General/multiple surgical solid-state laser system
No Description
J.MORITA MFG.CORP.
RZX3 Type: HF
In Commercial Distribution
- 04548213056545 ()
- Electrosurgical system
CellFX Handpiece
Pulse Biosciences, Inc.
FG2250-01
In Commercial Distribution
- 00850003231419 ()
CH03
- Electrosurgical system
CellFX Console
Pulse Biosciences, Inc.
FG2100-01
In Commercial Distribution
- 00850003231389 ()
CFX10
- Electrosurgical system
The NEUROMARK System is intended for the application of radiofrequency (RF) energy to create lesions in mucosal tissue in otolaryngology [also known as Ear, Nose and Throat (ENT)] procedures in patients with chronic rhinitis. The NEUROMARK System is indicated for use in otorhinolaryngology (ENT) surgery for creation of radiofrequency (RF) lesions to disrupt posterior nasal nerves in patients with chronic rhinitis. The NEUROMARK Device is designed for use with the NEUROMARK Radiofrequency Console via a flexible interface cable. The NEUROMARK Console delivers, monitors and controls RF energy to the device. The Console is mounted on an ergonomic mobile stand for ease of use. The Console includes a Graphical User Interface (GUI) which provides operational instructions for the procedure; directs the user to select nasal cavities for treatment, indicates when the device is in contact with tissue and ready to start treatment, provides status of therapy and indicates when the procedure is complete. The NEUROMARK Console works in conjunction with software.
NEURENT MEDICAL LIMITED
010-00089-000
In Commercial Distribution
- 05391537940118 ()
- Electrosurgical system
The NEUROMARK™ System is intended for the application of radiofrequency (RF) energy to create lesions in mucosal tissue in otolaryngology [also known as Ear, Nose and Throat (ENT)] procedures in patients with chronic rhinitis. The NEUROMARK™ System is indicated for use in otorhinolaryngology (ENT) surgery for creation of radiofrequency (RF) lesions to disrupt posterior nasal nerves in patients with chronic rhinitis.
The NEUROMARK™ Device is designed for use with the NEUROMARK™ Radiofrequency Generator via a flexible cable. The NEUROMARK™ Radiofrequency Generator delivers, monitors and controls RF energy to the device. The generator meets the following requirements: RF operating frequency of 460 – 480 kHz (± 5 kHz); bipolar low power energy delivery and feedback control with low overshoot capabilities. The NEUROMARK™ Radiofrequency Generator is mounted on an ergonomic mobile cart for ease of use. The mobile cart includes a handle and basket. The Graphical User Interface (GUI) provides operational instructions for the procedure; directs user to select nasal cavities for treatment, indicates when the device is apposed and primed to start treatment, provides status of therapy and indicates when the procedure is complete. The NEUROMARK™ Radiofrequency Generator works in conjunction with software.
NEURENT MEDICAL LIMITED
010-00043-000
Not in Commercial Distribution
- 05391537940026 ()
- Electrosurgical system
No Description
ELLIQUENCE, LLC
IEC4-SP
In Commercial Distribution
- 00846338010652 ()
- Electrosurgical system
No Description
ELLIQUENCE, LLC
IEC4-SM120
In Commercial Distribution
- 00846338001803 ()
- Electrosurgical system